07:00 , Oct 20, 2016 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Parkinson’s disease (PD) Rat studies suggest GRIA antagonists or GABA A receptor agonists could help treat L-DOPA-induced dyskinesia in PD. In a rat model of L-DOPA-induced dyskinesia in PD, infusion into the primary motor...
08:00 , Jan 31, 2011 |  BC Week In Review  |  Company News

Sunshine Biopharma, Binghamton University deal

The biotech and university signed a three-year deal to conduct preclinical and Phase I testing of Sunshine's Adva-27a to treat breast and prostate cancer. Sunshine will provide partial funding and will have exclusive rights to...